6. Where a patient’s follow-up is ensured by an ophthalmologist physician, the administration or prescription of an anti-glaucoma medication by the optometrist must conform to the treatment established by that physician or comply with the joint follow-up plan agreed to with the physician and entered in the patient’s record.
845-2018O.C. 845-2018, s. 6.